Researchers from the Van Andel Institute and the University of Colorado last month reported on the identification of a series of plasma-based microRNAs that could potentially be used as biomarkers for Parkinson's disease.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.
Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.
Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.
By analyzing tweets, Canadian researchers examine the public's view of gene patenting.
In this online seminar, Jo Vandesompele of the Center for Medical Genetics at Ghent University will discuss methods for improving the analysis of microRNA expression from a range of samples.